URGN EPS Estimates
UroGen Pharma Ltd.
$37.27
+$0.69(+1.89%)
39
Overall
40
Value
18
Tech
60
Quality
Market Cap
$1.79B
Volume
117.54K
52W Range
$16.18 - $50.81
Target Price
$60.00
URGN EPS estimates: the consensus estimate for UroGen Pharma Ltd.'s current fiscal year is -$0.20 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
URGN EPS Estimates
- EPS estimate, current quarter
- $0.38
- EPS estimate, next quarter
- $0.06
- EPS estimate, current year
- $-0.20
- EPS estimate, next year
- $3.49
- EPS growth, 3-year
- +12.79%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.19 |
| 2024 | $-2.96 |
| 2023 | $-3.55 |
| 2022 | $-4.81 |
| 2021 | $-4.96 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | URGN | $37.27 | +1.9% | 117.54K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |